Recent Press Releases


December 8, 2000 Myriad Genetics Acquires Exclusive Rights to Cancer Drug in Phase II Human Clinical Trials
December 8, 2000 Encore Pharmaceuticals Lincenses Lead Cancer Compound to Myriad Genetics
April 10, 2000 Encore Updates Clinical Development of E-7869 in Cancer
April 17, 2000 Encore Reports on Clinical Development Progress with Their Lead Drug Candidate E-7869
April 15, 1999 Encore Pharmaceuticals Begins Phase IIa Clinical Trial in Prostate Cancer Patients

Farmacia cialis online trattamento medico degli uomini.


Home | Corporate Profile | Intellectual Properties | Press Releases | Scientific References | Contact Us